Aspects on social egg freezing – current state in Bulgaria

Authors

  • D. Dyulgerova–Nikolova Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Science – Sofia, Bulgaria; SAGHAT IVF-unit "D-r Shterev" – Sofia, Bulgaria Author
  • I. Antonova SAGHAT IVF-unit "D-r Shterev" – Sofia, Bulgaria; Medical University, “Prof. Dr. Paraskev Stoyanov” – Varna, Bulgaria Author
  • L. Valkova SAGHAT IVF-unit "D-r Shterev" – Sofia, Bulgaria; Medical University, “Prof. Dr. Paraskev Stoyanov” – Varna, Bulgaria Author
  • T. Timeva SAGHAT IVF-unit "D-r Shterev" – Sofia, Bulgaria; University of Ruse “Angel Kanchev” – Ruse, Bulgaria Author
  • M. Yunakova Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Science – Sofia, Bulgaria; Medical University – Sofia Author
  • T. Milachich Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Science – Sofia, Bulgaria; SAGHAT IVF-unit "D-r Shterev" – Sofia, Bulgaria Author

DOI:

https://doi.org/10.2478/AMB-2024-0072

Keywords:

social freezing, oocyte cryopreservation, postpone reproduction, assisted reproduction

Abstract

Problem statement: Oocyte cryopreservation for non-medical reasons has been widely promoted among young women who tend to delay their reproduction. As the methodology has proved its safety and efficiency in the field of assisted reproduction technology and the embryo laboratory, the interest in oocyte cryopreservation has increased highly. However, do social freezers ever come back and use these oocytes, or they keep them as a safety boat with no real near-future plans for reproduction? Methods: The following study has been performed as a retrospective analysis of 296 women who had oocyte freezing procedure for non-medical (social) reasons, medical conditions (oncological treatment) and oocyte donation from January 2013 to June 2023 at Medical Complex Ob/ Gyn “Dr Shterev” – Sofia, Bulgaria. Results: Throughout the observed period, 190 women with 221 procedures vitrified their oocytes for future use. Only 9.47% of them had medical conditions and 7.36% were hindered to use their reproductive gametes at the day of 
the oocyte retrieval (absence of spermatozoa, sickness). The average age of the women in this group was 35.59 ± 1.5 years and the mean number of cryopreserved oocytes was 5.63 ± 1.4 per women. Compared to social cryopreserves, and bound to the Bulgarian 
legislation, the 106 women who donated their oocytes were younger (28.86 ± 1.5 years (p < 0.05)) with 7.34 ± 1.7 (p < 0.05) cryopreserved oocytes per donor. As the clinic has well represented program for oocyte donation 82.1% of the donors were used. In result, there were 37 clinical pregnancies with 47 children born. In the same period, only 46 (24.2%) women who stored their own gametes in our cryobank came back and claimed them for assisted reproduction. Nine clinical pregnancies had been registered and 10 children were born. An intriguing fact we can point from the medical history of the clear social freezers (SF) is the record of previous procedure(s) for abortion on demand. It was reported for 12% of the women in this group. Conclusion: According to the results we observed as evident that patients need more clarity towards the procedures for oocyte cryopreservation and consequent fertility treatment. We should rise more awareness to the most preferable age for cryopreservation and number of oocytes to be stored.

References

Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1(8486):884-6. doi: 10.1016/s0140-6736(86)90989-x.

De Proost M, Coene G, Nekkebroeck J, et al. ‘I feel that injustice is being done to me’: a qualitative study of women’s viewpoints on the (lack of) reimbursement for social egg freezing. BMC Med Ethics 23, 35 (2022). https://doi.org/10.1186/ s12910-022-00774-z

Borini A, Bonu MA, Coticchio G, et al. Pregnancies and births after oocyte cryopreservation. Fertil Steril. 2004;82(3):601-5.

doi: 10.1016/j.fertnstert.2004.04.025.

Benagiano G, Gianaroli L. The new Italian IVF legislation. Reprod Biomed Online. 2004; 9:117-25

Pai HD, Baid R, Palshetkar NP, et al. Oocyte Cryopreservation – Current Scenario and Future Perspectives: A Narrative Review. J Hum Reprod Sci. 2021;14(4):340-349. doi: 10.4103/jhrs.jhrs_173_21

Stoop D, Ermini B, Polyzos NP, et al. Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles. Human Reproduction, 2013;28(1),286, https://doi.org/10.1093/humrep/des396

Cohen M, Lindheim S, Sauer M. Donor age is paramount to success in oocyte donation. Human Reproduction, 1999;14(11),2755

, https://doi.org/10.1093/humrep/14.11.2755

Dyulgerova-Nikolova D, Milachich, T. Rare Sperm Freezing. 2021. 10.5772/intechopen.77538.

von Wolff M, Andersen CY, Woodruff TK, Nawroth F. FertiPROTEKT, Oncofertility Consortium and the Danish Fertility Preservation Networks – What Can We Learn From Their Experiences? Clin Med Insights Reprod Health. 2019 Apr 30;13. doi: 10.1177/1179558119845865.

Akhondi MM, Ardakani ZB, Warmelink JC. et al. Knowledge and beliefs about oocyte cryopreservation for medical and social reasons in female students: a cross-sectional survey. BMC Women’s Health, 2023, 23, 336. https://doi. org/10.1186/s12905-023-02481-2

Gambadauro P, Bränn E, Hadlaczky G. Acceptance and willingness-to-pay for oocyte cryopreservation in medical versus age-related fertility preservation scenarios among Swedish female university students. Sci Rep, 2023, 13, 5325. https:// doi.org/10.1038/s41598-023-32538-z

Fritz R, Jindal S. Reproductive aging and elective fertility preservation. J Ovarian Res, 2018, 11, 66. https://doi.org/10.1186/ s13048-018-0438-4

Pellestor F, et al. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes.

;112(2):195-203.

Cobo A, García-Velasco Juan A, Coello A, et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertility and Sterility, 2016;105(3),755-764.e8, https://doi. org/10.1016/j.fertnstert.2015.11.027.

Cobo A, García-Velasco Juan A, Remohí J, et al. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons, Fertility and Sterility, 2021;115(5), 1091-1101, https://doi.org/10.1016/j.fertnstert.2021.02.006.

Tsafrir A, Holzer H, Miron-Shatz T, et al. Why have women not returned to use their frozen oocytes?’: a 5-year follow-up of women after planned oocyte cryopreservation. Reproductive BioMedicine Online, 2021;43(6),1137-1145, https://doi. org/10.1016/j.rbmo.2021.08.026.

Ben-Rafael, Zion. The dilemma of social oocyte freezing: usage rate is too low to make it cost-effective. Reproductive biomedicine online 37.4 (2018): 443-448.

van Loendersloot, Laura L, et al. Expanding reproductive lifespan: a cost-effectiveness study on oocyte freezing. Human reproduction 26.11 (2011): 3054-3060.

Chen SU, Yang YS. Slow freezing or vitrification of oocytes: their effects on survival and meiotic spindles, and the time schedule for clinical practice. Taiwan J Obstet Gynecol. 2009;48(1):15-22. doi: 10.1016/S1028-4559(09)60030-9.

De Munck N, Verheyen G, Van Landuyt L, et al. Survival and post-warming in vitro competence of human oocytes after high security closed system vitrification. J Assist Reprod Genet. 2013;30(3):361-9. doi: 10.1007/s10815-0139930-3.

Kirillova A, Lysenkov S, Farmakovskaya M. et al. Should we transfer poor quality embryos? Fertil Res and Pract 6, 2 2020.

https://doi.org/10.1186/s40738-020-00072-5

Kadioglu N, Kahyaoğlu İ, Kaplanoğlu İ, et al. Evaluation of Clinical Outcomes after Poor-Quality Embryo Transfer and Prognostic Parameters. J Clin Med, 2023;12(19):6236. https://doi.org/10.3390/jcm12196236

Jamil M, Debbarh H, Kabit A, et al. Impact of the number of retrieved oocytes on IVF outcomes: Oocyte maturation, fertilization, embryo quality and implantation rate. Zygote, 2023, 31(1), 91-96. Doi :10.1017/S096719942200065X

Bonte D, Thys V, De Sutter P, et al. Vitrification negatively affects the Ca2+-releasing and activation potential of mouse oocytes, but vitrified oocytes are potentially useful for diagnostic purposes. Reproductive BioMedicine Online, 2020;40(1),13-25, https://doi.org/10.1016/j.rbmo.2019.09.012.

Tsai TE, Lin PH, Lian PF, et al. Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles. J Ovarian Res, 2022, 15, 102. https://doi.org/10.1186/s13048-022-01036-7

Delbaere I, Verbiest S, Tydén T. Knowledge about the impact of age on fertility: a brief review. Ups J Med Sci. 2020;125(2):167-174. doi: 10.1080/03009734.2019.1707913.

Teo UL, Kakkar P, El-Toukhy T. Current perspectives on social oocyte freezing, Journal of Obstetrics and Gynaecology, 2022, 42:3, 370-378, DOI: 10.1080/01443615.2021.1904220

Roque M, Haahr T, Esteves SC, Humaidan P. The POSEIDON stratification – moving from poor ovarian response to low prognosis. JBRA Assist Reprod. 2021;25(2):282-292. doi: 10.5935/1518-0557.20200100

Downloads

Published

20.11.2024

Issue

Section

ORIGINAL ARTICLES

How to Cite

Dyulgerova–Nikolova, D., Antonova, I., Valkova, L., Timeva, T., Yunakova, M., & Milachich, T. (2024). Aspects on social egg freezing – current state in Bulgaria. Acta Medica Bulgarica, 51(4), 14-21. https://doi.org/10.2478/AMB-2024-0072